Frontlight ResearchEarly access
HIV trials in Russia
1 of 2 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2Active, not recruitingDoravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)
- Where
- Kemerovo, Krasnodar, Krasnoyarsk, Moscow, Saint Petersburg
- Age
- 4 weeks to 11 years
- People
- 84 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT04375800